PHOTO BY TORY MATHER
For me, a late fall jaunt to the Laurel Highlands provided a timely chance to simply pause and breathe.
Standing on the edge of some rushing Ohiopyle falls, I could nearly conjure the buzz of the summertime crowds. Yet on…
It’s a great day to be a Lego or Pokémon fan and even better if you’re both. Ahead of Pokémon’s 30th anniversary, the two iconic toy brands are…
What if you could put a 10-inch tablet in your pocket as easily as your smartphone?
That’s no longer just a tech enthusiast’s dream.
At the Consumer Electronics Show in Las Vegas last week, Samsung showed off the Galaxy Z…
Build a large enough website with a large enough codebase, and you’ll eventually find that CSS presents challenges at scale. It’s no different at Meta, which is why we open-sourced StyleX, a solution for CSS at scale. StyleX combines the…
Aran Nayebi(opens in new window) jokes that his robot vacuum has a bigger brain than his two cats. But while the vacuum can only follow a preset path, Zoe and Shira leap, play and investigate the house with real…
Apple just made a big decision about the future of its in-house AI assistant.
In a statement posted to X, Google and Apple confirmed that the former’s Gemini AI models will serve as the…
Free trial can only be redeemed once per account after 1/12/2026.
*Nintendo Switch Online membership (sold separately) and Nintendo Account required for online features. Free trial automatically converts to 1-month auto-renewing membership at the…
A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its production of proteins has been discovered by researchers at Umeå University, Sweden. The discovery…
Last year I became uncomfortably well acquainted with suffering. In March I started experiencing excruciating pain in my right arm and shoulder – burning, zapping, energy-sapping pain that left me unable to think straight, emanating from a…
For patients with T3/T4 and Tany N-positive anal cancer, the use of radiotherapy dose escalation from 53.2 Gy to 58.8 Gy or 61.6 Gy in 28 fractions did not improve outcomes at 6 months, according to results from the phase 3 PLATO ACT 5 trial…